Table 4 Changes in international prostate symptoms score (IPSS) and uroflow rate (UFR) before and after treatment

From: Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone

  Before (n=32) Sildenafil (Sil) (n=32) Testosterone (T) (n=32) T+Sil (n=21)
IPSS 12.4±3.4 13.0±3.9 15.9±4.0 15.2±4.0
UFR 18.5±6.5 20.5±6.3 20.2±8.3 21.7±9.2